| Nanomedicine scale-up technologies: feasibilities and challenges R Paliwal, RJ Babu, S Palakurthi Aaps Pharmscitech 15 (6), 1527-1534, 2014 | 175 | 2014 |
| Amorphous-state characterization of efavirenz—polymer hot-melt extrusion systems for dissolution enhancement SK Sathigari, VK Radhakrishnan, VA Davis, DL Parsons, RJ Babu Journal of pharmaceutical sciences 101 (9), 3456-3464, 2012 | 121 | 2012 |
| Physicochemical characterization of efavirenz–cyclodextrin inclusion complexes S Sathigari, G Chadha, YHP Lee, N Wright, DL Parsons, VK Rangari, ... Aaps Pharmscitech 10 (1), 81-87, 2009 | 104 | 2009 |
| In vitro and in vivo evaluation of topical formulations of spantide II L Kikwai, RJ Babu, R Prado, A Kolot, CA Armstrong, JC Ansel, M Singh Aaps Pharmscitech 6 (4), E565-E572, 2005 | 95 | 2005 |
| Formulation of controlled release gellan gum macro beads of amoxicillin RJ Babu, S Sathigari, MT Kumar, JK Pandit Current drug delivery 7 (1), 36-43, 2010 | 90 | 2010 |
| Role of cyclodextrins in nanoparticle-based drug delivery systems H Shelley, RJ Babu Journal of pharmaceutical sciences 107 (7), 1741-1753, 2018 | 89 | 2018 |
| Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin RJ Babu, JK Pandit International journal of pharmaceutics 271 (1-2), 155-165, 2004 | 83 | 2004 |
| Formulation and in vitro evaluation of transdermal patches of melatonin N Kanikkannan, S Andega, S Burton, RJ Babu, M Singh Drug development and industrial pharmacy 30 (2), 205-212, 2004 | 83 | 2004 |
| Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems RJ Babu, JK Pandit International journal of pharmaceutics 288 (2), 325-334, 2005 | 80 | 2005 |
| Box-Behnken experimental design in the development of a nasal drug delivery system of model drug hydroxyurea: characterization of viscosity, in vitro drug release, droplet size … P Dayal, V Pillay, RJ Babu, M Singh Aaps Pharmscitech 6 (4), E573-E585, 2005 | 73 | 2005 |
| Alternatives to biological skin in permeation studies: Current trends and possibilities R Neupane, SHS Boddu, J Renukuntla, RJ Babu, AK Tiwari Pharmaceutics 12 (2), 152, 2020 | 71 | 2020 |
| Effect of vehicles on the transdermal delivery of melatonin across porcine skin in vitro L Kikwai, N Kanikkannan, RJ Babu, M Singh Journal of controlled release 83 (2), 307-311, 2002 | 63 | 2002 |
| Effect of penetration enhancers on the transdermal delivery of bupranolol through rat skin RJ Babu, JK Pandit Drug delivery 12 (3), 165-169, 2005 | 55 | 2005 |
| Lipid materials for topical and transdermal delivery of nanoemulsions KR Pawar, RJ Babu Critical Reviews™ in Therapeutic Drug Carrier Systems 31 (5), 2014 | 49 | 2014 |
| The influence of various methods of cold storage of skin on the permeation of melatonin and nimesulide RJ Babu, N Kanikkannan, L Kikwai, C Ortega, S Andega, K Ball, S Yim, ... Journal of controlled release 86 (1), 49-57, 2003 | 49 | 2003 |
| Biomaterial-derived calcium carbonate nanoparticles for enteric drug delivery D Render, T Samuel, H King, M Vig, S Jeelani, RJ Babu, V Rangari Journal of nanomaterials 2016, 2016 | 44 | 2016 |
| Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement GP Sanganwar, S Sathigari, RJ Babu, RB Gupta European Journal of Pharmaceutical Sciences 39 (1-3), 164-174, 2010 | 41 | 2010 |
| Effect of cyclodextrins on the complexation and nasal permeation of melatonin RJ Babu, P Dayal, M Singh Drug delivery 15 (6), 381-388, 2008 | 41 | 2008 |
| Therapeutic potential and utility of elacridar with respect to P-glycoprotein inhibition: An insight from the published in vitro, preclinical and clinical studies RP Dash, RJ Babu, NR Srinivas European journal of drug metabolism and pharmacokinetics 42 (6), 915-933, 2017 | 40 | 2017 |
| Two decades-long journey from riluzole to edaravone: revisiting the clinical pharmacokinetics of the only two amyotrophic lateral sclerosis therapeutics RP Dash, RJ Babu, NR Srinivas Clinical pharmacokinetics 57 (11), 1385-1398, 2018 | 37 | 2018 |
Mandip Singh SachdevaProfessor, FAMU College of PharmacyVerified email at famu.edu
